David F Hale insider trades
Open-market stock purchases and sales by David F Hale, Director at Dermata Therapeutics, Inc, from SEC Form 4 filings since Dec 31, 2009.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -83%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- DRMA Dermata Therapeutics, Inc: 1 buy, last Jan 2, 2026
- ONCT Oncternal Therapeutics, Inc: 4 buys, 1 sale, last Jun 20, 2024
- BIOC Biocept Inc: 4 buys, 6 sales, last Dec 9, 2021
- CNAT Conatus Pharmaceuticals Inc: 1 buy, last Jun 27, 2019
- SNTS Santarus Inc: 5 buys, last Jan 2, 2014
- SOMX Pernix Sleep, Inc: 1 sale, last Mar 6, 2013
- MITI Micromet, Inc: 1 sale, last Mar 7, 2012